Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: APC selectively mediates response to chemotherapeutic agents in breast cancer

Fig. 1

Gene expression of ATP-dependent binding cassette transporters. a Microarray analysis of mammary glands from ApcMin/+ and Apc+/+ mice at d16 of lactation show a decrease in ABCG2 and increase in MDR1 expression due to Apc mutation. b MDR1 gene expression in cells from MMTV-PyMT;ApcMin/+ and MMTV-PyMT;Apc+/+ mice after 24 h treatment with either solvent control, paclitaxel, cisplatin or doxorubicin. MDR1 expression was significantly increased in cells from MMTV-PyMT;ApcMin/+ mice after treatment with paclitaxel and doxorubicin but not cisplatin. c ABCG2 gene expression in cells from MMTV-PyMT;ApcMin/+ and MMTV-PyMT;Apc+/+ mice after treatment for 24 h with either solvent control, paclitaxel, cisplatin or doxorubicin. ABCG2 expression was not different between MMTV-PyMT;ApcMin/+ and MMTV-PyMT;Apc+/+ cells and chemotherapy treatment had no effect on ABCG2 expression. d Representative western blots for MDR1 and ABCG2 in cells from MMTV-PyMT;ApcMin/+ and MMTV-PyMT;Apc+/+ mice after treatment for 24 h with either solvent control, paclitaxel, cisplatin or doxorubicin. e Quantification of MDR1 western blots shows that MMTV-PyMT;ApcMin/+ cells have enhanced MDR1 expression when treated with doxorubicin. f Quantification of ABCG2 western blots shows that MMTV-PyMT;Apc+/+ cells have elevated ABCG2 protein expression compared to MMTV-PyMT;ApcMin/+ cells. Results in B, C, E and F are shown as the means ± SEM from 3 independent experiments; *P < 0.05 when comparing MMTV-PyMT;ApcMin/+ to MMTV-PyMT;Apc+/+ cells and #P < 0.05 when comparing MMTV-PyMT;ApcMin/+ cells treated with solvent control or chemotherapy agent.

Back to article page